Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziz Nazha

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Best Practice & Research. Clinical Haematology|November 30, 2019
Does mutational burden add to other prognostic factors in MDS?Aziz Nazha
Blood|March 4, 2021
Should I rock the boat? When to stop TKIs in CMLAziz Nazha
Hematology. American Society of Hematology. Education Program|December 4, 2018
The MDS genomics-prognosis symbiosisAziz Nazha
Blood|November 18, 2021
Can the computer see what the human sees?Aziz Nazha
Current Hematologic Malignancy Reports|November 24, 2023
Unlocking the Potential of Artificial Intelligence in Acute Myeloid Leukemia and Myelodysplastic SyndromesAbdulrahman Alhajahjeh, Aziz Nazha
Current Hematologic Malignancy Reports|October 12, 2018
Online and Social Media Resources for Patients with MDSNour Abuhadra, Aziz Nazha
Leukemia & Lymphoma|July 27, 2013
Acute myeloid leukemia in the elderly: do we know who should be treated and how?Aziz Nazha, Farhad Ravandi
Hematology/Oncology Clinics of North America|February 25, 2020
Novel Prognostic Models for Myelodysplastic SyndromesJacob Shreve, Aziz Nazha
Clinical Hematology International|September 4, 2020
The Evolving Landscape of Myelodysplastic Syndrome PrognosticationJacob Shreve, Aziz Nazha
Current Hematologic Malignancy Reports|August 28, 2017
Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDSAziz Nazha, Rafael Bejar
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Best Practice & Research. Clinical Haematology|November 30, 2019
Does mutational burden add to other prognostic factors in MDS?Aziz Nazha
Blood|March 4, 2021
Should I rock the boat? When to stop TKIs in CMLAziz Nazha
Hematology. American Society of Hematology. Education Program|December 4, 2018
The MDS genomics-prognosis symbiosisAziz Nazha
Blood|November 18, 2021
Can the computer see what the human sees?Aziz Nazha
Current Hematologic Malignancy Reports|November 24, 2023
Unlocking the Potential of Artificial Intelligence in Acute Myeloid Leukemia and Myelodysplastic SyndromesAbdulrahman Alhajahjeh, Aziz Nazha
Current Hematologic Malignancy Reports|October 12, 2018
Online and Social Media Resources for Patients with MDSNour Abuhadra, Aziz Nazha
Leukemia & Lymphoma|July 27, 2013
Acute myeloid leukemia in the elderly: do we know who should be treated and how?Aziz Nazha, Farhad Ravandi
Hematology/Oncology Clinics of North America|February 25, 2020
Novel Prognostic Models for Myelodysplastic SyndromesJacob Shreve, Aziz Nazha
Clinical Hematology International|September 4, 2020
The Evolving Landscape of Myelodysplastic Syndrome PrognosticationJacob Shreve, Aziz Nazha
Current Hematologic Malignancy Reports|August 28, 2017
Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDSAziz Nazha, Rafael Bejar
Pageof 13